Streck is an industry leader in the development and manufacturing of products for clinical and research laboratories. Established in 1971, Streck is one of the industry’s earliest pioneers. Streck’s founder, Dr. Wayne Ryan, helped develop the first hematology reference controls for automated instruments. Streck’s passion for service helps meet the evolving needs of laboratories around the world. Streck’s pursuit of innovative solutions has produced an extensive list of patented products.
Streck’s core technology is cell stabilization. Hematology controls and accompanying support products make up a significant portion of the business. The company also offers immunology, sed-rate instruments, blood collection tubes and molecular diagnostic products. Streck customers benefit from a free inter-laboratory quality control program known as STATS®.
Streck control products test the performance and limits of instruments and reagents, helping laboratories meet regulatory and accreditation requirements. The most important characteristics of Streck controls are the stability and physical similarities to real patient samples. Closely resembling patient blood makes it easier for technicians to detect any problems with their processes or instruments.
Based in Omaha, Nebraska, Streck has a specialized and experienced work force of more than 300. Our campus encompasses 200,000 square feet with dedicated space built to support Research and Development, Manufacturing, and Administrative functions.
Streck's Quality Management System complies with the FDA Quality System Regulation (QSR) and is registered compliant with ISO 9001, ISO 13485, and SOR/98-282 (Canadian Medical Devices Regulations). In addition, Streck manufactures more than 30 products that have been declared compliant with 98/79/EC, which is the European Union's In Vitro Diagnostic Medical Devices Directive.